- Home
- U vs LNTH Comparison
U vs LNTH Comparison
Compare U & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- U
- LNTH
- Stock Information
- Founded
- U 2004
- LNTH 1956
- Country
- U United States
- LNTH United States
- Employees
- U N/A
- LNTH N/A
- Industry
- U Retail: Computer Software & Peripheral Equipment
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- U Technology
- LNTH Health Care
- Exchange
- U Nasdaq
- LNTH Nasdaq
- Market Cap
- U 7.7B
- LNTH 7.5B
- IPO Year
- U 2020
- LNTH 2015
- Fundamental
- Price
- U $22.83
- LNTH $81.24
- Analyst Decision
- U Buy
- LNTH Strong Buy
- Analyst Count
- U 13
- LNTH 5
- Target Price
- U $23.79
- LNTH $133.80
- AVG Volume (30 Days)
- U 8.7M
- LNTH 1.4M
- Earning Date
- U 05-07-2025
- LNTH 05-07-2025
- Dividend Yield
- U N/A
- LNTH N/A
- EPS Growth
- U N/A
- LNTH N/A
- EPS
- U N/A
- LNTH 3.53
- Revenue
- U $1,787,875,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- U N/A
- LNTH $4.96
- Revenue Next Year
- U $9.62
- LNTH $10.25
- P/E Ratio
- U N/A
- LNTH $23.00
- Revenue Growth
- U N/A
- LNTH 12.53
- 52 Week Low
- U $13.90
- LNTH $74.34
- 52 Week High
- U $30.88
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- U 60.86
- LNTH 32.82
- Support Level
- U $20.78
- LNTH $77.01
- Resistance Level
- U $22.56
- LNTH $83.60
- Average True Range (ATR)
- U 1.06
- LNTH 3.77
- MACD
- U 0.12
- LNTH -2.21
- Stochastic Oscillator
- U 92.92
- LNTH 13.26
About U Unity Software Inc.
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run, and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC, and other Americas, and key revenue is derived from the EMEA region. The products are used in the gaming industry, retail, automotive, architecture, engineering, and construction.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.